The current valuation score of Milestone Pharmaceuticals Inc is 6.03, ranking 365 out of 387 in the Biotechnology & Medical Research industry. Its current P/E ratio is -2.07, which is -62.81% below the recent high of -0.77 and -81.80% above the recent low of -3.76.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.